Literature DB >> 19577348

Acute kidney injury during warfarin therapy associated with obstructive tubular red blood cell casts: a report of 9 cases.

Sergey V Brodsky1, Anjali Satoskar, Jun Chen, Gyongyi Nadasdy, Jeremiah W Eagen, Mirza Hamirani, Lee Hebert, Edward Calomeni, Tibor Nadasdy.   

Abstract

Acute kidney injury (AKI) during warfarin therapy usually is hemodynamic secondary to massive blood loss. Here, we report pathological findings in kidney biopsy specimens from 9 patients with warfarin overdose, hematuria, and AKI. Kidney biopsy specimens from patients on warfarin therapy with AKI were identified in our database within a 5-year period. Each kidney biopsy specimen was evaluated by using semiquantitative morphometric techniques, and medical history was reviewed for conditions explaining AKI. Biopsy specimens with morphological findings of active glomerulonephritis and active inflammatory lesions were excluded from the study. Biopsy specimens from 9 patients were selected. At presentation with AKI, each patient had an abnormal international normalized ratio (mean 4.4 +/- 0.7 IU) and increased serum creatinine level (mean, 4.3 +/- 0.8 mg/dL). Morphologically, each biopsy specimen showed evidence of acute tubular injury and glomerular hemorrhage: red blood cells (RBCs) in Bowman space and numerous occlusive RBC casts in tubules. Each biopsy specimen showed chronic kidney injury. Six of 9 patients did not recover from AKI. These data suggest that warfarin therapy can result in AKI by causing glomerular hemorrhage and renal tubular obstruction by RBC casts. Our experience suggests that this may be a potentially serious complication of warfarin therapy, especially in older patients with underlying chronic kidney injury.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19577348     DOI: 10.1053/j.ajkd.2009.04.024

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  77 in total

Review 1.  Differential diagnosis of glomerular disease: a systematic and inclusive approach.

Authors:  Lee A Hebert; Samir Parikh; Jason Prosek; Tibor Nadasdy; Brad H Rovin
Journal:  Am J Nephrol       Date:  2013-09-13       Impact factor: 3.754

2.  Anticoagulant-related nephropathy in a patient with IgA nephropathy.

Authors:  Mário Góis; Ariana Azevedo; Fernanda Carvalho; Fernando Nolasco
Journal:  BMJ Case Rep       Date:  2017-02-20

3.  Warfarin-related nephropathy modeled by nephron reduction and excessive anticoagulation.

Authors:  Kyle Ware; Polina Brodsky; Anjali A Satoskar; Tibor Nadasdy; Gyongyi Nadasdy; Haifeng Wu; Brad H Rovin; Udayan Bhatt; Jon Von Visger; Lee A Hebert; Sergey V Brodsky
Journal:  J Am Soc Nephrol       Date:  2011-09-01       Impact factor: 10.121

4.  Anticoagulant-Related Nephropathy: It's the Real McCoy.

Authors:  Richard J Glassock
Journal:  Clin J Am Soc Nephrol       Date:  2019-05-21       Impact factor: 8.237

5.  A case of (double) ANCA-negative granulomatosis with polyangiitis (Wegener's).

Authors:  Tetsuya Kashiwagi; Naoaki Hayama; Emiko Fujita; Keiko Hara; Akiko Mii; Yukinari Masuda; Yasuhiko Iino; Akira Shimizu; Yasuo Katayama
Journal:  CEN Case Rep       Date:  2012-06-26

6.  Perirenal hemorrhage: rare complication of warfarin coagulopathy.

Authors:  Ryo Koda; Tetsuro Takeda
Journal:  Clin Exp Nephrol       Date:  2012-10-23       Impact factor: 2.801

Review 7.  The emerging threat of superwarfarins: history, detection, mechanisms, and countermeasures.

Authors:  Douglas L Feinstein; Belinda S Akpa; Manuela A Ayee; Anne I Boullerne; David Braun; Sergey V Brodsky; David Gidalevitz; Zane Hauck; Sergey Kalinin; Kathy Kowal; Ivan Kuzmenko; Kinga Lis; Natalia Marangoni; Michael W Martynowycz; Israel Rubinstein; Richard van Breemen; Kyle Ware; Guy Weinberg
Journal:  Ann N Y Acad Sci       Date:  2016-05-31       Impact factor: 5.691

8.  Incidence and risk factors for acute kidney injury in patients with excessive anticoagulation on warfarin: a retrospective study.

Authors:  Siavash Piran; Hugh Traquair; Noel Chan; Marlene Robinson; Sam Schulman
Journal:  J Thromb Thrombolysis       Date:  2018-05       Impact factor: 2.300

Review 9.  Dabigatran etexilate: appropriate use in patients with chronic kidney disease and in the elderly patients.

Authors:  Mauro Molteni; Mario Bo; Giovanni Di Minno; Giuseppe Di Pasquale; Simonetta Genovesi; Danilo Toni; Paolo Verdecchia
Journal:  Intern Emerg Med       Date:  2017-04-24       Impact factor: 3.397

Review 10.  Oral anticoagulants and risk of nephropathy.

Authors:  Vinay Narasimha Krishna; David G Warnock; Nakshatra Saxena; Dana V Rizk
Journal:  Drug Saf       Date:  2015-06       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.